Claims for Patent: 6,306,609

Summary for Patent: 6,306,609

Title:	Methods for the detection of nitric oxide in fluid media
Abstract:	In accordance with the present invention, there are provided articles for use in non-invasive measurements of nitric oxide levels in a variety of fluid media, e.g., in mammalian body fluids. Articles according to the present invention comprise a nitric oxide trapping agent contained within a vessel, wherein the vessel comprises a semi-permeable membrane. Nitric oxide diffuses through the semi-permeable membrane and is trapped therein for subsequent quantitative analysis. Articles of the present invention are particularly useful in selectively detecting nitric oxide in the presence of other NO.sub.x species.
Inventor(s):	Lai; Ching-San (Encinitas, CA)
Assignee:	Medinox, Inc. (San Diego, CA) MCW Research Foundation, Inc. (Milwaukee, WI)
Application Number:	09/274,718
Patent Claims:	1. An article comprising a nitric oxide trapping agent contained within a container; wherein at least a portion of said container comprises a semi-permeable membrane wherein said membrane is permeable to neutral gas molecules but is impermeable to charged molecules, and wherein the contents of said container communicate with fluid media in contact with said container via said semi-permeable membrane. 2. An article according to claim 1 wherein said nitric oxide trapping agent is selected from the group consisting of chelating agents, carboxy-2-phenyl-4,4,5,5-tetramethylimidazoline-oxyl-1-oxyl-3-oxide, nitrones, oxygen, thiol compounds, physiologically compatible aqueous media, apolar oxygenated solvents, guanylate cyclase/GTP system, superoxide anion radicals, peroxynitrite, xanthine/xanthine oxidase system, peroxides, superoxide dismutase, antibodies directed against free radical adducts and Griess reagent. 3. An article according to claim 2 wherein said chelating agents are selected from metal ion-containing complexes of dithiocarbamates, the hydroxamic acid siderophore ferrioxamine B and derivatives thereof, metal ion-containing complexes of diethylenetriaminepentaacetic acid, hemoglobins, cobalamin (vitamin B12) and derivatives thereof, porphyrins, heme, myoglobins or meso-2,3-dimercaptosuccinic acid. 4. An article according to claim 3 wherein said metal ions are selected from iron, copper, cobalt, zinc or manganese ions. 5. An article according to claim 3 wherein said dithiocarbamates are selected from compounds having the structure: wherein each R is independently a C.sub.1 up to C.sub.18 alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, heterocyclic, substituted heterocyclic, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, alkylaryl, substituted alkylaryl, arylalkyl, substituted arylalkyl, arylalkenyl, substituted arylalkenyl, arylalkynyl, substituted arylalkynyl, aroyl, substituted aroyl, acyl, or substituted acyl, or the two R groups cooperate to form a 5-, 6- or 7-membered ring wherein said ring includes N and the two R groups. 6. An article according to claim 2 wherein said thiol compounds are thiol containing amino acids, thiol containing peptides, thiol containing proteins, glutathione, thiol containing carbohydrates or thiol containing nucleotides. 7. An article according to claim 2 wherein said physiologically compatible aqueous media is selected from saline, sterile water, phosphate-buffered saline, culture media or balanced salt solutions. 8. An article according to claim 2 wherein said apolar oxygenated solvent is a fluorinated cycloaliphatic compound, a fluorinated aromatic compound or a fluorinated carboxylic acid. 9. An article according to claim 2 wherein said nitric oxide trapping agent is selected from superoxide anion radicals, peroxynitrite, xanthine/xanthine oxidase system, peroxides or Griess reagent. 10. An article according to claim 1 wherein said container is suitable for placing into a culture vessel, a subject's respiratory system, an exhaust system, a ventilation system, or a handheld monitoring device. 11. An article according to claim 1 wherein said container comprises a flexible bag constructed of said semi-permeable membrane. 12. An article according to claim 1, wherein said container comprises a rigid or semi-rigid non-porous receptacle containing said nitric oxide trapping agent, wherein said receptacle has at least one opening therein, and wherein said nitric oxide trapping agent is retained within said receptacle by said semi-permeable membrane. 13. An article according to claim 1 wherein said container comprises a pouch containing said nitric oxide trapping agent, wherein at least a portion of said nitric oxide trapping agent is in fluid communication with fluid media contacting said container via said semi-permeable membrane. 14. An article according to claim 1 wherein said container is round, oblong, square, rectangular, tubular or spherical.

Details for Patent 6,306,609

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2016-11-08